FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The American Journal of Managed Care3h
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Fierce Healthcare9h
FTC formally sues PBMs over insulin prices and warns manufacturers
Express Scripts files suit against FTC, demands retraction of report on PBM industry These PBMs value high rebates from ...
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
The enforcement action is part of an escalating conflict between the FTC and the three pharmacy benefit managers that ...
The Washington Post on MSN3h
FTC sues pharmacy insurance managers, alleging unfair drug prices
In a statement, the FTC wrote that an executive at a PBM acknowledged this strategy for insulins, saying that the big three PBMs continue to “drink down the tasty … rebates.” PBMs pushed back Friday ...
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
American Pharmacists Association applauds FTC action on PBMs' alleged inflation of insulin drug prices
Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically ...
Modern Healthcare6h
FTC targets three biggest PBMs over insulin rebates
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...
Becker's Hospital Review45m
FTC sues nation's 3 largest PBMs: 10 notes
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.